(0)
LONDON, ON, April 14, 2021 /PRNewswire/ Alimentiv Health Trust, the parent company of Alimentiv, Inc. (formerly Robarts Clinical Trials), a specialized global gastrointestinal (GI) contract research organization (CRO), and McDougall Scientific Ltd., a niche CRO, announced today the launch of AcelaBio, a commercial state-of-the-art research laboratory delivering histopathology and precision medicine services for global clinical trials.
AcelaBio s primary focus is to accelerate biomarker discovery and development by providing end-to-end specialty histopathology & precision medicine services for global clinical trials. This state-of-the-art laboratory has strong synergies with Alimentiv (CRO) that will enhance the ability to deliver clinical research to pharmaceutical and biotech industry partners.
Biocept Reports 2020 Fourth Quarter and Full Year Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Truck drivers failing to be adequately drug tested
ccjdigital.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ccjdigital.com Daily Mail and Mail on Sunday newspapers.
Truck drivers failing to be adequately drug tested
ccjdigital.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ccjdigital.com Daily Mail and Mail on Sunday newspapers.